GRAN TIERRA ENERGY INC
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
Contents
Item 1. Financial Statements
Condensed Consolidated Statements of Operations (Unaudited)
(Thousands of U.S. Dollars, Except for Share and Per Share Amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| OIL SALES (Note 6) | $157,577 | $144,190 |
| EXPENSES | ||
| Operating | 48,466 | 41,369 |
| Transportation | 4,584 | 3,066 |
| Depletion, depreciation and accretion (Note 3) | 56,150 | 52,196 |
| General and administrative (Note 9) | 12,877 | 12,696 |
| Severance | 1,266 | — |
| Foreign exchange (gain) loss | (815) | 1,702 |
| Other gain | — | (1,090) |
| Interest expense (Note 4) | 18,424 | 11,836 |
| 140,952 | 121,775 | |
| INTEREST INCOME | 692 | 768 |
| INCOME BEFORE INCOME TAXES | 17,317 | 23,183 |
| INCOME TAX EXPENSE | ||
| Current (Note 7) | 3,916 | 17,606 |
| Deferred (Note 7) | 13,479 | 15,277 |
| 17,395 | 32,883 | |
| NET AND COMPREHENSIVE LOSS | $(78) | $(9,700) |
| NET LOSS PER SHARE (1) | ||
| - BASIC and DILUTED | $— | $(0.28) |
| WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC and DILUTED (Note 5) | 31,813,072 | 34,451,400 |
Condensed Consolidated Balance Sheets (Unaudited)
(Thousands of U.S. Dollars, Except for Share Amounts)
| As at March 31, 2024 | As at December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents (Note 10) | $126,618 | $62,146 |
| Accounts receivable | 10,763 | 12,359 |
| Inventory | 25,887 | 29,039 |
| Other current assets (Note 9 and 10) | 3,648 | 8,920 |
| Total Current Assets | 166,916 | 112,464 |
| Oil and Gas Properties | ||
| Proved | 1,061,807 | 1,055,070 |
| Unproved | 57,945 | 54,116 |
| Total Oil and Gas Properties | 1,119,752 | 1,109,186 |
| Other capital assets | 37,900 | 33,664 |
| Total Property, Plant and Equipment (Note 3) | 1,157,652 | 1,142,850 |
| Other Long-Term Assets | ||
| Deferred tax assets | 9,548 | 10,923 |
| Taxes receivable | 60,303 | 52,089 |
| Other long-term assets (Note 9 and 10) | 7,991 | 7,963 |
| Total Other Long-Term Assets | 77,842 | 70,975 |
| Total Assets | $1,402,410 | $1,326,289 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | $207,447 | $187,007 |
| Credit facility (Note 4) | — | 35,609 |
| Current portion of long-term debt (Note 4 and 9) | 24,677 | — |
| Taxes payable | 22,173 | 27,219 |
| Equity compensation award liability (Note 5) | 3,424 | 10,419 |
| Total Current Liabilities | 257,721 | 260,254 |
| Long-Term Liabilities | ||
| Long-term debt (Note 4 and 9) | 583,099 | 519,532 |
| Deferred tax liabilities | 72,799 | 57,453 |
| Asset retirement obligation | 75,826 | 73,029 |
| Equity compensation award liability (Note 5) | 9,895 | 8,750 |
| Other long-term liabilities | 11,059 | 10,877 |
| Total Long-Term Liabilities | 752,678 | 669,641 |
| Contingencies (Note 8) | ||
| Shareholders' Equity (1) | ||
| Common Stock (31,429,826 and 32,275,113 issued, 31,401,214 and 32,246,501 outstanding shares of Common Stock, par value $0.001 per share, as at March 31, 2024 and December 31, 2023, respectively), (Note 5) | 9,935 | 9,936 |
| Additional paid-in capital | 1,245,387 | 1,249,651 |
| Treasury Stock (Note 5) | (203) | (163) |
| Deficit | (863,108) | (863,030) |
| Total Shareholders’ Equity | 392,011 | 396,394 |
| Total Liabilities and Shareholders’ Equity | $1,402,410 | $1,326,289 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Thousands of U.S. Dollars)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating Activities | ||
| Net loss | $(78) | $(9,700) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depletion, depreciation and accretion (Note 3) | 56,150 | 52,196 |
| Deferred tax expense (Note 7) | 13,479 | 15,277 |
| Stock-based compensation expense (Note 5) | 3,361 | 1,500 |
| Amortization of debt issuance costs (Note 4) | 3,306 | 781 |
| Unrealized foreign exchange (gain) loss | (2,266) | 514 |
| Other gain | — | (1,090) |
| Cash settlement of asset retirement obligation | (183) | — |
| Non-cash lease expenses | 1,413 | 1,144 |
| Lease payments | (1,058) | (606) |
| Net change in assets and liabilities from operating activities (Note 10) | (13,297) | (10,763) |
| Net cash provided by operating activities | 60,827 | 49,253 |
| Investing Activities | ||
| Additions to property, plant and equipment | (55,331) | (71,062) |
| Changes in non-cash investing working capital (Note 10) | 16,531 | 14,871 |
| Net cash used in investing activities | (38,800) | (56,191) |
| Financing Activities | ||
| Proceeds from issuance of Senior Notes, net of issuance costs (Note 4) | 85,638 | — |
| Repayment of debt (Note 4) | (36,364) | — |
| Debt issuance costs (Note 4) | — | (50) |
| Purchase of Senior Notes | — | (4,225) |
| Re-purchase of shares of Common Stock (Note 5) | (4,948) | (10,718) |
| Proceeds from exercise of stock options | 161 | — |
| Lease payments | (1,972) | (1,105) |
| Net cash provided by (used in) financing activities | 42,515 | (16,098) |
| Foreign exchange (loss) gain on cash, cash equivalents and restricted cash and cash equivalents | (42) | 2,214 |
| Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | 64,500 | (20,822) |
| Cash and cash equivalents and restricted cash and cash equivalents, beginning of period (Note 10) | 71,038 | 133,358 |
| Cash and cash equivalents and restricted cash and cash equivalents, end of period (Note 10) | $135,538 | $112,536 |
| Supplemental cash flow disclosures (Note 10) | ||
Condensed Consolidated Statements of Shareholders’ Equity (Unaudited)
(Thousands of U.S. Dollars)
| Three Months Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Share Capital (1) | ||
| Balance, beginning of period | $9,936 | $10,272 |
| Cancellation of shares of Common Stock (Note 5) | (1) | — |
| Balance, end of period | $9,935 | $10,272 |
| Additional Paid-in Capital | ||
| Balance, beginning of period | $1,249,651 | $1,291,354 |
| Exercise of stock options | 161 | — |
| Cancellation of shares of Common Stock (Note 5) | (4,907) | — |
| Stock-based compensation (Note 5) | 482 | 619 |
| Balance, end of period | $1,245,387 | $1,291,973 |
| Treasury Stock | ||
| Balance, beginning of period | $(163) | $(27,317) |
| Re-purchase of shares of Common Stock (Note 5) | (4,948) | (10,718) |
| Cancellation of shares of Common Stock (Note 5) | 4,908 | — |
| Balance, end of period | $(203) | $(38,035) |
| Deficit | ||
| Balance, beginning of period | $(863,030) | $(856,743) |
| Net loss | (78) | (9,700) |
| Balance, end of period | $(863,108) | $(866,443) |
| Total Shareholders’ Equity | $392,011 | $397,767 |
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(Expressed in U.S. Dollars, unless otherwise indicated)
- Description of Business
Gran Tierra Energy Inc. a Delaware corporation (the “Company” or “Gran Tierra”), is a publicly traded company focused on international oil and natural gas exploration and production with assets currently in Colombia and Ecuador.
- Significant Accounting Policies
These interim unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The information furnished herein reflects all normal recurring adjustments that are, in the opinion of management, necessary for the fair presentation of results for the interim periods.
The note disclosure requirements of annual audited consolidated financial statements provide additional disclosures required for interim unaudited condensed consolidated financial statements. Accordingly, these interim unaudited condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements as at and for the year ended December 31, 2023, included in the Company’s 2023 Annual Report on Form 10-K.
The Company’s significant accounting policies are described in Note 2 of the consolidated financial statements, which are included in the Company’s 2023 Annual Report on Form 10-K and are the same policies followed in these interim unaudited condensed consolidated financial statements. The Company has evaluated all subsequent events to the date these interim unaudited condensed consolidated financial statements were issued.
- Property, Plant and Equipment
| (Thousands of U.S. Dollars) | As at March 31, 2024 | As at December 31, 2023 |
|---|---|---|
| Oil and natural gas properties | ||
| Proved | $4,933,920 | $4,876,185 |
| Unproved | 57,945 | 54,116 |
| 4,991,865 | 4,930,301 | |
| Other (1) | 81,013 | 73,505 |
| 5,072,878 | 5,003,806 | |
| Accumulated depletion, depreciation and impairment | (3,915,226) | (3,860,956) |
| $1,157,652 | $1,142,850 | |
(1) The “other” category includes right-of-use assets for operating and finance leases of $60.4 million, which had a net book value of $36.3 million as at March 31, 2024 (December 31, 2023 - $53.3 million, which had a net book value of $32.4 million).
During the three months ended March 31, 2024, the Company entered into new lease contracts related to power generation and safety equipment, and capitalized $6.1 million right-of-use assets related to those contracts.
For the three months ended March 31, 2024 and 2023, respectively, the Company had no ceiling test impairment losses. The Company used a 12-month unweighted average of the first-day-of the month Brent price prior to the ending date of the periods March 31, 2024 and 2023 of$81.58 and$95.99 per bbl, respectively, for the purpose of the ceiling test calculations.
- Debt and Debt Issuance Costs
The Company’s debt as at March 31, 2024, and December 31, 2023, was as follows:
| (Thousands of U.S. Dollars) | As at March 31, 2024 | As at December 31, 2023 |
|---|---|---|
| Current | ||
| Credit facility | $— | $36,364 |
| 6.25% Senior Notes, due February 2025 (“6.25% Senior Notes”) | 24,828 | — |
| Unamortized debt issuance costs | (151) | (755) |
| $24,677 | $35,609 | |
| Long-Term | ||
| 6.25% Senior Notes, due February 2025 (“6.25% Senior Notes”) | $— | $24,828 |
| 7.75% Senior Notes, due May 2027 (“7.75% Senior Notes”) | 24,201 | 24,201 |
| 9.50% Senior Notes, due October 2029 (“9.50% Senior Notes”) | 587,590 | 487,590 |
| Unamortized Senior Notes discount | (38,164) | (27,958) |
| Unamortized Senior Notes issuance costs | (17,465) | (15,679) |
| 556,162 | 492,982 | |
| Long-term lease obligation (1) | 26,937 | 26,550 |
| $583,099 | $519,532 | |
| Total Debt | $607,776 | $555,141 |
(1)The current portion of the lease obligation has been included in accounts payable and accrued liabilities on the Company’s balance sheet and totaled $15.2 million as at March 31, 2024 (December 31, 2023 - $12.1 million).
Credit Facility
As at December 31, 2023, the Company had a $36.4 million balance outstanding under the Company’s credit facility. On February 6, 2024, the outstanding balance under the credit facility of $36.4 million was fully re-paid and the credit facility was terminated.
Senior Notes
On February 6, 2024, the Company issued an additional $100.0 million of 9.50% Senior Notes due October 2029 (the “new 9.50% Senior Notes”), and received cash proceeds of $88.0 million. The new 9.50% Senior Notes have the same terms and provisions as the previously issued $487.6 million 9.50% Senior Notes except for the issue price. The new 9.50% Senior Notes accrue interest from October 20, 2023, the date of issuance of previously issued 9.50% Senior Notes. The Company received a cash payment of $2.8 million related to the accrued interest of the new 9.50% Senior Notes.
Leases
During the three months ended March 31, 2024, the Company recorded three new finance leases totaling $6.1 million, which have lease terms ranging fromtwo tothree years and weighted average discount rates of 9.6%.
Interest Expense
The following table presents the total interest expense recognized in the accompanying interim unaudited condensed consolidated statements of operations:
| Three Months Ended March 31, | ||
|---|---|---|
| (Thousands of U.S. Dollars) | 2024 | 2023 |
| Contractual interest and other financing expenses | $15,118 | $11,055 |
| Amortization of debt issuance costs | 3,306 | 781 |
| $18,424 | $11,836 | |
- Share Capital
| Shares of Common Stock | |
|---|---|
| Shares issued at December 31, 2023 | 32,275,113 |
| Treasury shares | (28,612) |
| Shares issued and outstanding at December 31, 2023 | 32,246,501 |
| Shares issued on option exercise | 41,379 |
| Shares re-purchased and cancelled | (858,054) |
| Shares issued at March 31, 2024 | 31,429,826 |
| Treasury shares | (28,612) |
| Shares issued and outstanding at March 31, 2024 | 31,401,214 |
During the year ended December 31, 2023, the Company implemented a share re-purchase program (the “2023 Program”) through the facilities of the Toronto Stock Exchange (“TSX”), the NYSE American (the “NYSE”) and eligible alternative trading platforms in Canada or the United States. Under the 2023 Program, the Company is able to purchase at prevailing market prices up to 3,234,914 shares of Common Stock, representing approximately 10% of the public float as of October 20, 2023. The 2023 Program will expire on November 2, 2024, or earlier if the 10% maximum is reached.
During the three months ended March 31, 2024, the Company re-purchased 886,666 shares at a weighted average price of $5.58 per share (three months ended March 31, 2023 -1,308,212 shares under the 2022 program at a weighted average price of $8.19 per share). As of March 31, 2024, the Company cancelled 28,612 shares held as treasury shares at December 31, 2023, and cancelled 858,054 shares re-purchased during the three months ended March 31, 2024. During the period from October 20, 2023 to April 29, 2024, the Company has re-purchased 1,997,500 shares under the 2023 Program.
Equity Compensation Awards
The following table provides information about performance stock units(“PSUs”), deferred share units (“DSUs”), restricted share units (“RSUs”) and stock option activity for the three months ended March 31, 2024:
| PSUs · DSUs · RSUs · Stock Options | |||||
|---|---|---|---|---|---|
| Number of Outstanding Share Units | Number of Outstanding Share Units | Number of Outstanding Share Units | Number of Outstanding Stock Options | Weighted Average Exercise Price/Stock Option ($) | |
| Balance, December 31, 2023 | 3,896,356 | 776,610 | — | 2,027,807 | 9.93 |
| Granted | 2,185,352 | 40,942 | 523,719 | 1,970 | 5.64 |
| Exercised | (1,847,322) | — | — | (41,379) | 3.90 |
| Forfeited | (122,267) | — | — | (43,451) | 9.86 |
| Expired | — | — | — | (154,270) | 23.18 |
| Balance, at March 31, 2024 | 4,112,119 | 817,552 | 523,719 | 1,790,677 | 8.92 |
For the three months ended March 31, 2024 and 2023, there was $3.4 million and $1.5 million of stock-based compensation expense, respectively.
As at March 31, 2024, there was $26.8 million (December 31, 2023 - $8.6 million) of unrecognized compensation costs related to unvested PSUs, RSUs and stock options, which are expected to be recognized over a weighted-average period of 2.3 years. During the three months ended March 31, 2024, the Company paid out $10.4 million for PSUs vested on December 31, 2023 (three months ended March 31, 2023 - $15.1 million for PSUs vested on December 31, 2022).
During the three months ended March 31, 2024, the Company awarded 0.5 million RSUs to employees pursuant to the existing 2007 Equity Incentive Plan. Under the 2007 Equity Incentive Plan, RSU units will vest one-third each year over athree-year period. Upon vesting, RSUs entitle the holder to receive either the underlying number of shares of the Company’s Common Stock or a cash payment equal to the value of the underlying shares of the Company’s Common Stock. The Company intends to settle RSUs outstanding as at March 31, 2024, in cash.
Net Income (Loss) per Share
Basic net income or loss per share is calculated by dividing net income or loss attributable to common shareholders by the weighted average number of shares of Common Stock issued and outstanding during each period.
Diluted net income or loss per share is calculated using the treasury stock method for share-based compensation arrangements. The treasury stock method assumes that any proceeds obtained on the exercise of share-based compensation arrangements would be used to purchase shares of Common Stock at the average market price during the period. The weighted average number of shares is then adjusted by the difference between the number of shares issued from the exercise of share-based compensation arrangements and shares re-purchased from the related proceeds. Anti-dilutive shares represent potentially dilutive securities excluded from the computation of diluted income or loss per share as their impact would be anti-dilutive.
Weighted Average Shares Outstanding
For the three months ended March 31, 2024 and 2023, all options were excluded from the diluted loss per share calculation as the options were anti-dilutive.
- Revenue
The Company’s revenues are generated from oil sales at prices that reflect the blended prices received upon shipment by the purchaser at defined sales points or defined by contract relative to ICE Brent and adjusted for Vasconia or Castilla (Colombia sales) or Oriente (Ecuador sales) crude differentials, quality and transportation discounts and premiums each month. For the three months ended March 31, 2024,100% of the Company’s revenue resulted from oil sales (three months ended March 31, 2023 -100%). During the three months ended March 31, 2024, quality and transportation discounts were 19% of the average ICE Brent price (three months ended March 31, 2023 -22%).
During the three months ended March 31, 2024 and 2023, the Company’s production was sold primarily to one major customer in Colombia and Ecuador, representing 100% and 97% of the total sales volumes, respectively.
As at March 31, 2024, accounts receivable includednil accrued sales revenue related to March 2024 production (December 31, 2023 -nil related to December 2023 production).
- Taxes
The Company’s effective tax rate was 100% for the three months ended March 31, 2024, compared to 142% in the comparative period of 2023.
Current income tax expense was $3.9 million for the three months ended March 31, 2024, compared to $17.6 million in the corresponding period of 2023, primarily due to a decrease in taxable income.
The deferred income tax expense for the three months ended March 31, 2024, was $13.5 million compared to $15.3 million in the corresponding period of 2023 mainly as a result of tax depreciation being higher than accounting depreciation and the use of tax losses to offset taxable income in Colombia.
For the three months ended March 31, 2023, the deferred income tax expense was $15.3 million mainly as a result of tax depreciation being higher than accounting depreciation and the use of tax losses to offset taxable income in Colombia.
For the three months ended March 31, 2024, the difference between the effective tax rate of 100% and the 45% Colombian tax rate was primarily due to an increase in the impact of foreign taxes, increase in the valuation allowance, non-deductible foreign translation adjustments, non-deductible stock-based compensation and other permanent differences.
For the three months ended March 31, 2023, the difference between the effective tax rate of 142% and the 50% Colombian tax rate was primarily due to an increase in non-deductible foreign translation adjustments, the impact of foreign taxes, non-deductible royalty in Colombia and increase in the valuation allowance. These were partially offset by other permanent differences.
- Contingencies
Legal Proceedings
Gran Tierra has several lawsuits and claims pending. The outcome of the lawsuits and disputes cannot be predicted with certainty; Gran Tierra believes the resolution of these matters would not have a material adverse effect on the Company’s consolidated financial position, results of operations, or cash flows. Gran Tierra records costs as they are incurred or become probable and determinable.
Letters of Credit and Other Credit Support
At March 31, 2024, the Company had provided letters of credit and other credit support totaling $222.6 million (December 31, 2023 - $220.1 million) as a security relating to work commitment guarantees in Colombia and Ecuador contained in exploration contracts, the Suroriente Block extension agreement and other capital or operating requirements. Approximately $123.0 million relates to the Suroriente Block extension agreement.
- Financial Instruments and Fair Value Measurement
Financial Instruments
Financial instruments are initially recorded at fair value, defined as the price that would be received to sell an asset or paid to market participants to settle liability at the measurement date. For financial instruments carried at fair value, GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy consists of three broad levels:
Level 1 - Inputs representing quoted market prices in active markets for identical assets and liabilities
Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the assets and liabilities, either directly or indirectly
Level 3 - Unobservable inputs for assets and liabilities
At March 31, 2024, the Company’s financial instruments recognized on the balance sheet consist of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, current portion of long-term debt, long-term debt and other long-term liabilities. The Company uses appropriate valuation techniques based on the available information to measure the fair values of assets and liabilities.
Fair Value Measurement
The following table presents the Company’s fair value measurements of its financial instruments as of March 31, 2024, and December 31, 2023:
| (Thousands of U.S. Dollars) | As at March 31, 2024 | As at December 31, 2023 |
|---|---|---|
| Assets | ||
| Prepaid equity forward (“PEF”) - current (1) | $— | $5,630 |
| Liabilities | ||
| 6.25% Senior Notes | $23,242 | $22,994 |
| 7.75% Senior Notes | 20,692 | 20,744 |
| 9.50% Senior Notes | 549,579 | 429,018 |
| $593,513 | $472,756 | |
| Assets | ||
| Restricted cash and cash equivalents - long-term (2) | $7,778 | $7,750 |
| Liabilities | ||
| Credit facility | $— | $35,609 |
(1) The current portion of PEF is included in the other current assets on the Company’s condensed consolidated balance sheet.
(2)The long-term portion of restricted cash is included in the other long-term assets on the Company’s condensed consolidated balance sheet.
The fair values of cash and cash equivalents, current restricted cash and cash equivalents, accounts receivable and accounts payable and accrued liabilities approximate their carrying amounts due to the short-term maturity of these instruments.
Restricted Cash - Long-Term
The fair value of long-term restricted cash and cash equivalents approximate its carrying value because interest rates are variable and reflective of market rates.
Prepaid Equity Forward
As at March 31, 2024, the Company hadno outstanding PEF asset (As at December 31, 2023 -1.0 million notional shares with a fair value of $5.6 million). For the three months ended March 31, 2024 and 2023, the Company recorded $0.3 million and $1.7 million loss in general and administrative expenses relating to the PEF, respectively.
During the three months ended March 31, 2024, the Company settled all outstanding notional PEF shares and received net proceeds of $5.1 million resulting in a $0.3 million loss on settlement.
Senior Notes
Financial instruments recorded at amortized cost at March 31, 2024, were the Senior Notes (Note 4).
At March 31, 2024, the carrying amounts of the 6.25% Senior Notes,7.75% Senior Notes and 9.50% Senior Notes were $24.7 million, $23.8 million, and $532.4 million, respectively, which represented the aggregate principal amount less unamortized debt issuance costs and discounts, and the fair values were $23.2 million, $20.7 million, and$549.6 million, respectively.
- Supplemental Cash Flow Information
The following table provides a reconciliation of cash and cash equivalents and restricted cash and cash equivalents shown as a sum of these amounts in the interim unaudited condensed consolidated statements of cash flows:
| As at March 31, · As at December 31, | ||||
|---|---|---|---|---|
| (Thousands of U.S. Dollars) | 2024 | 2023 | 2023 | 2022 |
| Cash and cash equivalents | $126,618 | $105,684 | $62,146 | $126,873 |
| Restricted cash and cash equivalents - current (1) | 1,142 | 1,142 | 1,142 | 1,142 |
| Restricted cash and cash equivalents - long-term (2) | 7,778 | 5,710 | 7,750 | 5,343 |
| $135,538 | $112,536 | $71,038 | $133,358 | |
(1) Included in other current assets on the Company’s condensed consolidated balance sheet.
(2) Included in other long-term assets on the Company’s condensed consolidated balance sheet.
Net changes in assets and liabilities from operating activities were as follows:
| Three Months Ended March 31, | ||
|---|---|---|
| (Thousands of U.S. Dollars) | 2024 | 2023 |
| Accounts receivable and other long-term assets | $1,639 | $(3,022) |
| PEF | 6,218 | 7,806 |
| Prepaids and inventory | 1,967 | 740 |
| Accounts payable and accrued and other long-term liabilities | (9,995) | (17,252) |
| Taxes receivable and payable | (13,126) | 965 |
| Net changes in assets and liabilities from operating activities | $(13,297) | $(10,763) |
Changes in non-cash investing working capital for the three months ended March 31, 2024, were comprised of an increase in accounts payable and accrued liabilities of $16.6 million and an increase in accounts receivable of $0.1 million (three months ended March 31, 2023, an increase in accounts payable and accrued liabilities of $14.9 million).
The following table provides additional supplemental cash flow disclosures:
| Three Months Ended March 31, | ||
|---|---|---|
| (Thousands of U.S. Dollars) | 2024 | 2023 |
| Cash paid for withholding taxes | $11,681 | $8,461 |
| Cash paid for interest | $1,224 | $8,781 |
| Non-cash investing activities: | ||
| Net liabilities related to property, plant and equipment, end of period | $63,947 | $69,989 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.